Examination of use of diabetes drug pioglitazone and risk of bladder cancer

21 julio 2015

Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, however a small increased risk could not be excluded, according to a new study.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/WnZYct9ak1g» height=»1″ width=»1″ alt=»»/